Article
Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach.
PloS one - 1 Jan 2015
Lin Guigao, Yi Lang, Zhang Kuo, Wang Lunan, Zhang Rui, Xie Jiehong, Li Jinming
Abstract excerpt
Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the correct information for CYP2C19 genotype-directed antiplatelet therapy, a proficiency testing scheme was set up to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.